Search Results - Gahr, Maximilian
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances by Gahr, Maximilian, Connemann, Bernhard J., Muche, Rainer, Zeiss, René, Wolf, Almuth
Published 2021Text -
13
Intranasal Pregabalin Administration: A Review of the Literature and the Worldwide Spontaneous Reporting System of Adverse Drug Reactions by Elsayed, Mohamed, Zeiss, René, Gahr, Maximilian, Connemann, Bernhard J., Schönfeldt-Lecuona, Carlos
Published 2019Text -
14
-
15
-
16
Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report by Gahr, Maximilian, Gastl, Regina, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Freudenmann, Roland W
Published 2012Text -
17
-
18
Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany by Elsayed, Mohamed, Abdel-kahaar, Emaad, Gahr, Maximilian, Connemann, Bernhard J., Denkinger, Michael, Schönfeldt-Lecuona, Carlos
Published 2020Text -
19
Lithium Therapy Associated With Renal and Upper and Lower Urinary Tract Tumors: Results From a Retrospective Single-Center Analysis by Gahr, Maximilian, Wezel, Felix, Bolenz, Christian, Connemann, Bernhard J., Schönfeldt-Lecuona, Carlos, Muche, Rainer, Fohrer, Christian
Published 2019Text -
20
Correspondence (letter to the editor): Better Risk Assessment for Individual Substances by Freudenmann, Roland W, Freudenmann, Ninja, Zurowski, Bartosz, Schönfeldt-Lecuona, Carlos, Connemann, Bernhard J, Gahr, Maximilian, Freudenmann, Roland
Published 2015Text